



Title: Inspiratory muscle training for improving inspiratory muscle strength and 
functional capacity in older adults: a systematic review and meta-analysis. 
 
Abstract 
Background: The ageing process can result in the decrease of respiratory muscle strength and 
consequently increased work of breathing and associated breathlessness during activities of 
daily living in older adults.  
Objective: This systematic review and meta-analysis aims to determine the effects of 
inspiratory muscle training (IMT) in healthy older adults.  
Methods: A systematic literature search was conducted across four databases 
(Medline/Pubmed, Web of Science, Cochrane Library and CINAHL) using a search strategy 
consisting of both MeSH and text words including older adults, inspiratory muscle training, 
and functional capacity. The eligibility criteria for selecting studies involved controlled trials 
investigating inspiratory muscle training via resistive or threshold loading in older adults (>60 
years) without a long-term condition.  
Results: Seven studies provided mean change scores for inspiratory muscle pressure and 3 
studies for functional capacity. A significant improvement was found for maximal inspiratory 
pressure (PImax) following training (n=7, 3.03 [2.44, 3.61], p=<0.00001) but not for functional 
capacity (n=3, 2.42 [-1.28, 6.12], p=0.20). There was no significant correlation between 
baseline PImax and post-intervention change in PImax values (n=7, r=0.342, p=0.453).  
Conclusions: IMT can be beneficial in terms of improving inspiratory muscle strength in older 
adults regardless of their initial degree of inspiratory muscle weakness. Further research is 
required to investigate the effect of IMT on functional capacity and quality of life in older 






1.0 – Introduction 
 
1.1 Background: 
Respiratory function is reduced during the ageing process due to structural and physiological 
changes of the respiratory system [1]. These changes are characterised by decreased recoil 
pressure of the lung, respiratory muscle function and chest wall compliance [2]. During ageing 
we see a decrease in muscle mass, strength and function which can accelerate the decline in 
respiratory muscle strength in older adults assessed by maximal inspiratory pressure (PImax) 
measurements [3]. Several studies in healthy older adults [4-6] have reported PImax values as 
low as those reported in patients with lung or heart disease [6-8].   
Decreased respiratory muscle strength leads to increased residual volume, functional residual 
capacity and consequently increased work of breathing and associated breathlessness during 
activities of daily living in older adults [9].  Therefore, exertional breathlessness in older adults 
may compromise an individual’s daily functional capacity and quality of life [10]. 
Reduced respiratory muscle strength and functional capacity is often seen in patients with lung 
or heart disease [11, 12]. In these patients, an effective method to combat inspiratory muscle 
weakness is inspiratory muscle training (IMT). Several studies have been conducted 
investigating the effect of IMT in various respiratory [7, 13, 14] and cardiovascular disorders 
[8, 15, 16]. Previous meta-analyses have suggested that IMT can improve inspiratory muscle 
strength (reflected by an increase in maximal inspiratory pressure), six-minute walking 
distance (6MWD) and quality of life in chronic obstructive pulmonary disease (COPD) [17, 
18] and chronic heart failure (CHF) [19]. 
Due to the age-related decline in respiratory muscle function, it is likely that IMT will also 




systematic review has started to investigate IMT in healthy older adults with the authors 
suggesting a positive trend for IMT in improving inspiratory muscle strength [20]. It should be 
noted, however, that this review also included frail participants with comorbidities and extreme 
debilitation [21, 22] that could affect the magnitude of improvement in PImax. Accordingly, 
the present systematic review and meta-analysis focuses on the effects of IMT in healthy older 
adults without frailty or associated comorbidities given that in this population, reduced 
respiratory muscle strength is associated with a decline in pulmonary function [23], reduced 
physical performance [24], and constitutes an independent risk factor for myocardial infarction 
and cardiovascular mortality [25]. Thus, interventions that increase respiratory muscle function 
may have an important clinical impact in healthy older adults. 
 
1.2 -  Review objective: 
To systematically review and perform a meta-analysis on the effects of inspiratory muscle 











2.0 – Methods: 
 
2.1 - Search strategy: 
This prospectively registered systematic review (CRD42019155163; 
https://www.crd.york.ac.uk/prospero/) followed the Cochrane Handbook for Systematic 
Reviews of Interventions [26] and the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines [27]. Electronic database (Medline/PubMed, Cochrane 
Library, Web of Science and CINAHL) were searched from August 2019 to February 2020.  
The final search strategy included relevant MeSH Terms, Text Words and Publication Types 
relating to the population (e.g. “aged” and “older adults”), the intervention (e.g. “inspiratory 
muscle training” and “breathing exercises”), the outcomes (e.g. “exercise tolerance”, “quality 
of life” and “maxim* inspiratory”) and the design (e.g. “random*”, “clinical trial” and 
“experimental study”). These terms were constructed and grouped by Boolean logic with no 
restrictions on publication date. The full PubMed search strategy can be found in Appendix 1.  
 
2.2 – Inclusion and exclusion criteria: 
MeSH Terms/Text Words including “frail elderly”, “frail” and “frailty” were included in the 
search strategy due to the finding that, during pre-scoping, these keywords were associated 
with older populations with weaker inspiratory muscles undertaking IMT programmes [28]. 
The MeSH Term “breathing exercises” was also included as, during pre-scoping, it was found 
to be associated with inspiratory muscle training in some studies [6, 28-30]. Studies were 
considered eligible if they fulfilled the pre-determined participants, interventions, comparisons 




Initial screening of titles and abstracts and assessment of full texts were performed 
independently by two authors (blinded for review) who were blinded to each other’s decisions. 
Any disagreements between the authors were sent to a third author (blinded for review). 
 
2.3 – Data extraction: 
Data was extracted in terms of the following subheadings. 1) author information (first author 
and year of publication), 2) participant characteristics (age, gender, baseline maximal 
inspiratory pressure; PImax), 3) mode of IMT and supervision, 4) time, intensity and progression 
of IMT, 5) frequency and duration of IMT, 6) control and 7) outcomes assessed. 
 
2.4 – Quality assessment: 
The PEDro quality scale was used to assess internal and external validity of the included studies 
[31]. Two authors (blinded for review) independently reviewed each included study on the 
following domains of the PEDro scale: eligibility criteria, random allocation, concealed 
allocation, baseline similarity, blinding of subjects, therapist and assessor, measures obtained 
from more than 85% of subjects initially allocated to groups, full intention to treat, group 
comparison, and point measures and measures of variability. PEDro scale scores 9-11 were 
considered excellent, 6-8 good, 4-5 fair and ≤3 poor [31] . No study was excluded based on 
poor quality. 
 
2.5 – Data analysis: 
Meta-analyses of the studies were performed using the software Review Manager (RevMan 
V5.3; Cochrane Collaboration, Oxford, UK). Outcomes were continuous and change scores 




with 95% confidence intervals. The heterogeneity of studies were assessed by the I2 value, and 
were classified as might not be important (0-40%), moderate heterogeneity (30-60%), 
substantial heterogeneity (50-90%), and considerable heterogeneity (75-100%) [26]. A small 
minimum clinically important difference (MCID) in functional capacity was observed if 
participants in the IMT groups improved their 6MWD by above 20m and a substantial MCID 
if the improvement was over 50m [32]. A random-effects model was used for the meta-analyses 
as variation in methods were found between included studies beyond random sampling. 
Pearson’s correlation analysis was performed in order to determine the association between 
baseline PImax and change in PImax following IMT within included studies. The level of 
significance for all analyses was set at p < 0.05.  
 
3.0 – Results: 
The databases yielded 986 studies (Figure 1). Following the removal of 181 duplicates and 
screening of 805 titles/abstracts, 19 articles remained for full-text screening of which 11 were 
excluded. Overall, 8 studies were included in this systematic review with one of these studies 
[5] excluded from the meta-analysis due to insufficient data reported (Table 1). The full 


































Figure 1. PRISMA flow diagram of studies through database search and selection process; n=number. 
Records identified through 
database searching (n = 986)  
PUBMED: n=579                      
               Cochrane: n=229 
Web of Science: n=149 
                CINAHL: n=29 
 
Additional records identified 
through other sources  
(n =0) 
Records after duplicates removed  
(n = 805) 
Records screened  
(n = 805) 
Records excluded  
(n = 786) 
Full-text articles assessed 
for eligibility  
(n = 19) 
Full-text articles 
excluded, with reasons  
(n = 11) 
Wrong intervention (n=1) 
No reported data for 
outcome measures (n=3) 
No full-text availability 
(n=2) 
Wrong population (n=3) 
Wrong/no comparators 
(n=2) 
Studies included in 
qualitative synthesis  
(n = 8) 
Studies included in 
quantitative synthesis 
(meta-analysis)  































Excluded from meta-analyses, 
with reasons (n=1) 





Table 1. Characteristics of included studies 
Author Year N 
(I/C) 












duration of IMT 
Albuquerque 
























supervised a week 
8-10 sets of 5-6 
reps at 40-70% 
PImax 
 
5 sessions a week 
for 6 weeks 
 
Aznar-Lain 






IMT: 68.5 ± 
6.3 






IMT: 54.1 ± 
9.2 









8-10 sets of 5-6 
reps at 50-80% 
PImax, 1-minute 
rest between sets 
 
5 sessions per 
week 
 (3 during week 1) 
for 8 weeks 
 






IMT: 75 ± 6 





IMT: 76.0 ± 
27.4 









30 breaths, 50% 
PImax, able to 
increase 
resistance when 
30 breaths were 
achievable with 
ease 
Twice daily, 8 
weeks 
 






IMT: 70.6 ± 
4.8 




IMT: 59.1 ± 
19.2 






supervised a week 
 




PImax every week 
5 sessions per 
week for 6 weeks 
 






IMT: 69 ± 3 





IMT: 82 ± 27 







30 breaths, 50% 
PImax, able to 
increase 
resistance when 
30 breaths were 
achievable with 
ease 












IMT: 64 ± 3 





IMT: 84 ± 18 






supervised a week 
 
30 repetitions, 
50% PImax. Load 
adjusted to 
maintain 50% 
PImax once a week 
5 sessions per 
week 
 for 5 weeks 
 






IMT: 68.3 ± 
5.2 






IMT: 73.3 ± 
12.2 








8 cycles of 2-













IMT: 64.8 ± 
2.5 





IMT: 69 ± 20 








sessions: 3 sets of 
10 reps at 10RM. 
Endurance 
sessions: 40 
breaths at 40RM. 
Strength sessions: 
5 sets of 5 reps at 
5RM 
12 sessions per 
week, 6 days, 8 
weeks. 
Hypertrophy - 8 
sessions per 
week, endurance - 
2 sessions, 
strength - 2 
sessions 
Footnote: 6MWT, six-minute walk test; BMI, body mass index; CG, control group; IMT, inspiratory muscle training; PImax, maximal inspiratory pressure; PEmax, maximal 
expiratory pressure; MVPA, moderate to vigorous physical activity; MVV, maximal voluntary ventilation; PAL, physical activity levels; QoL, quality of life; RM, repetition 




3.1 – Characteristics of included subjects: 
The included studies comprised of 239 participants and had a mean age of 68.2 years (range 
64-75) and an average baseline PImax of 72.3cmH2O (59-89cmH2O). Participants were healthy 
older adults with no reported diseases that could influence inspiratory muscle strength.  
 
3.2 – Quality assessment: 
The risk of bias of included studies can be found in Appendix 4. The mean PEDro score for 
included studies was 6.4 and ranged from 4 to 9 (fair to excellent), suggesting a fairly low risk 
of bias towards the main outcome measures. The most frequent omissions in the quality of 
study design or reporting included: allocation of participants to groups was not concealed [4-
6, 28-30, 33], the therapist applying treatment was not blinded [4-6, 28-30, 33, 34] and 
assessors were not blinded [6, 29, 30]. Furthermore, two studies did not randomise participants 
to intervention or control groups [5, 6].  
 
3.3 – Interventions: 
All studies used a threshold inspiratory loading device with the addition of one study using a 
device that delivered both inspiratory and expiratory threshold loading [30]. Training protocols 
used inspiratory pressures that ranged from 30% to 80% PImax, with the majority of studies 
using training intensities of 30-60% PImax [28, 29, 33, 34]. The shortest duration of inspiratory 
muscle training was 5 weeks [33] and the longest was 8 weeks [4, 28-30]. At least one 
supervised training a week was reported in four out of the eight included studies [5, 6, 33, 34]. 
SHAM-IMT was used in the control condition of six studies [4, 5, 28, 29, 33, 34], with the 
control groups within the remaining studies either not participating in any training protocol 




3.4 – Outcome measures: 
All studies (n=8) used maximal inspiratory pressure (PImax; cmH2O) to reflect inspiratory 
muscle strength as an outcome measure [4-6, 28-30, 33, 34]. Three studies used the distance 
covered during a six-minute walk test (6MWD; meters) to reflect functional capacity [6, 29, 
33]. 
 
3.5 - Meta-analysis of included studies: 
3.5.1 – Inspiratory muscle strength: 
Seven studies [4, 6, 28-30, 33, 34] with 212 participants provided mean change scores for 
pooling. The meta-analysis showed a positive effect of inspiratory muscle training on maximal 
inspiratory pressure (n=7, 3.03 [2.44, 3.61], p <0.001; Figure 2). The average increase in 
maximal inspiratory pressure in the intervention was 26.3±4.9cmH2O compared to a 
3.7±4.1cmH2O in the control. The meta-analysis showed moderate heterogeneity (I
2=47%). No 
significant correlation was found between baseline PImax and post-intervention change in PImax 
expressed as absolute values (n=7, r=0.342, p=0.453; Figure 3) and percentage change from 
baseline (n=7, r=-0.490, p=0.264; Figure 4). 
 
3.5.2 – Six-minute walk distance: 
Three studies [6, 29, 33] with 101 participants provided mean change scores for pooling. 
Inspiratory muscle training showed no significant effect on the distance covered during a six-
minute walk test (n=3, 2.42 [-1.28, 6.12], p=0.20; Figure 2), however it can be considered to 
result in a small MCID [32]. The average increase in 6MWD following IMT was 24.7±22.1m 
in the intervention groups compared to 9±8.6m in the control groups. The meta-analysis 





Figure 2. Mean difference (95% CI) from baseline of the effect of inspiratory muscle training on inspiratory muscle strength (measured by maximal 
inspiratory pressure; n=7) and six-minute walk test distance (n=3) compared to control. 
















Figure 3. The relationship between baseline maximal inspiratory pressure (PImax) values and delta (Δ) 














Figure 4. The relationship between baseline maximal inspiratory pressure (PImax) values and percentage 




























































4.0 – Discussion:  
The present systematic review and meta-analysis suggests that specific IMT can significantly 
increase inspiratory muscle strength, reflected by an increase in maximal inspiratory pressure 
(cmH2O). This meta-analysis showed an effect size of 3.03 (2.44, 3.61) and can be categorised 
as a huge positive effect [35]. There was no significant change in six-minute walk distance 
(6MWD) following IMT, however, the improvement observed in this meta-analysis could be 
considered clinically meaningful as participants improved by over 20m [32]. This meta-
analysis also showed a large effect size (2.42 [-1.28, 6.12]). Due to the lack of statistical 
significance, high heterogeneity (I2=97%), and small number of included studies (n=3), more 
research is needed to determine the true effect of IMT on functional capacity in healthy older 
adults. 
 
4.1 – Interpretation of findings: 
Previous meta-analyses investigating the effect of IMT have typically reported average 
increases in PImax in COPD patients by 13 cmH2O [18], 11.6 cmH2O [17] and 16 cmH2O [36], 
as well as increase in PImax by 20 cmH2O [19] in chronic heart failure (CHF) patients. The 
present study suggests that IMT is also beneficial in improving inspiratory muscle strength in 
older adults without a long-term condition, reflected by an average increase of 26.3±4.9cmH2O 
within the experimental groups compared to a non-significant average change of 3.7± 
4.1cmH2O within the control groups.  
The mechanisms of improved PImax following IMT are likely due to structural and functional 
adaptations to the training stimulus, including strength, speed of shortening and power output 
[37]. In this case, the majority of studies used a moderate training load of 30-60% PImax, which 




secondary to hypertrophy of inspiratory muscles [39, 40]. The present review provides 
evidence that hypertrophy is related to the improvement in PImax as two included studies [29, 
34] reported increases in diaphragm thickness following IMT.  
The average improvement in functional capacity, reflected by an increase of 24.7±22.1m, 
following IMT in older adults within the present meta-analysis did not reach statistical 
significance. Previous research has used both distribution- and anchor-based methods to 
determine a small minimum clinically important difference (MCID) of 20m and a substantial 
MCID of 50m for the 6MWD in community-dwelling older adults [32], suggesting that the 
improvement observed in this meta-analysis may be clinically meaningful. Mills and 
colleagues [29] suggested that the observed lack of improvement in functional capacity was 
due to participants having a higher predicted baseline 6MWD (102-103%) [41] compared to 
the lower values of 90% in the healthy older group in the study by Huang et al. [6]. Baseline 
6MWD values were in line with predicted values for healthy older adults [41]. Rodrigues et al. 
[33], suggested that the improvement in functional capacity is likely due to a greater 
improvement in PImax compared to that observed previously [29]. Furthermore, the greater 
increase in distance covered (44m) observed by Huang et al. [6] could be related to the 
participants in the IMT group having lower baseline PImax values (59.1 ± 19.2cmH2O) 
compared to Rodrigues et al. [33] (84 ± 18cmH2O) and Mills et al. [29] (82 ± 27cmH2O).  It 
should be noted that the control group used in Huang et al. [6] consisted of participants with 
COPD and not older  adults without COPD, however baseline values for age, PImax, and 6MWD 
were similar between groups. 
Unfortunately, quality of life could not be included as an outcome measure within this meta-
analysis due to different questionnaires used between included studies, along with insufficient 
data reported. Albuquerque et al. [5] found that IMT had no significant effect on any of the 




significant increase in the physical component score following IMT. Mills et al. [29] used the 
Older Person’s Quality of Life Questionnaire (OPQOL-35) but did not find any significant 
changes following the training programme.  
IMT has been shown to improve various other outcome measures in older adults, including: 
increased diaphragm thickness [29, 34], moderate-vigorous physical activity levels [4], time to 
exhaustion exercise tests [4], peak oxygen uptake (VO2 peak) [4], balance [28], maximal 
expiratory pressure peak inspiratory flow rate (PIFR) [28, 29], cardiac autonomic modulation 
[33], and dyspnoea scores [6]. However, some studies report conflicting results including no 
significant effect of IMT on physical activity levels [29] and dyspnoea levels [21]. IMT that 
induces significant improvements in PImax can also reduce breathlessness in COPD [42] and 
CHF patients [43], however, when Huang and colleagues [6] investigated the relationship 
between the difference in PImax and the difference in dyspnea scores following IMT in healthy 
older adults , no significant correlation was observed. The authors suggested that this was due 
to a ceiling effect as participants reported relatively high baseline dyspnea scores.  
A recent systematic review investigated the effects of IMT in an older population [20]. Due to 
a large heterogeneity in participant characteristics, however, the authors did not perform a 
meta-analysis on their included studies. Two studies [21, 22] that were included in the review 
conducted by Seixas et al.  [20] were excluded from the present systematic review and meta-
analysis due to a considerable amount of the participants having comorbidities that could 
significantly affect inspiratory muscle strength. Furthermore, the participants were 
significantly older than in the remaining studies (84.5 years compared to 68.2 years) and had 
lower baseline PImax values (33.6cmH2O compared to 73.3 cmH2O). The lack of improvement 
in PImax following IMT within these two studies (6.7 and 2.8cmH2O) contradicts previous 
literature which has suggested that patients with pronounced inspiratory muscle weakness 




functional capacity in COPD [18] and CHF [44]. In the present review, correlation analysis of 
included studies showed no significant association between baseline inspiratory muscle 
strength and the post-IMT change in PImax (Figure 3) and percentage change in PImax from 
baseline (Figure 4), suggesting that IMT is beneficial in older adults regardless of their initial 
degree of inspiratory muscle weakness. Accordingly, IMT would be beneficial even in older 
adults with a wide range of inspiratory muscle weakness. 
Cebria I Iranzo et al. [21, 22] suggested that the lack of improvement following the training 
programme is likely due to the extreme debilitation and institutionalisation of the older adults 
[21]. Furthermore, a significant improvement in PImax following IMT was only observable 
when compared to the decreased values within the control group [22]. This suggests that IMT 
in frail older adults with sarcopenia may be beneficial in preventing the age-related decline in 
respiratory muscle strength, which is evident within this population [45]. 
The study conducted by Albuquerque et al. [5] was also excluded from the meta-analysis due 
to the data expressed as median and interquartile range (IQR). Nevertheless, this study showed 
significant improvements in inspiratory muscle strength and functional capacity following a 
six-week IMT programme compared to the SHAM-IMT control.  
 
4.2 - Quality of the evidence:  
The quality of the included studies ranged from fair to excellent on the PEDro quality scale 
(Appendix 4). As most of the studies involved mainly unsupervised training sessions, the lack 
of a blinded therapist in all included studies is unlikely to significantly increase the risk of bias 
in the present meta-analysis. However, the lack of reported intention to treat [4-6, 28-30, 33, 
34] and concealed allocation [4-6, 28-30, 33] in the majority of included studies reduced the 




4.3 – Strengths and limitations: 
This is the first meta-analysis to investigate the effects of IMT during healthy ageing and was 
conducted in line with both the Cochrane Handbook for Systematic Reviews of Interventions 
and the PRISMA guidelines. The main limitations of this systematic review and meta-analysis 
include the considerable heterogeneity along with the lack of reported intention to treat analysis 
and concealed allocation to groups.  The high heterogeneity in the 6MWD meta-analysis is 
likely due to the variation of methods and participant characteristics between studies, such as 
the intensity, frequency and duration of IMT along with baseline PImax values. Future research 
should aim to standardise methods of IMT in this population to reduce heterogeneity. 
Furthermore, since three studies [30, 33, 34] were performed in older women only, sex 
differences could have affected the absolute values for baseline PImax, however, as absolute 
change scores were used when pooling the data (Figure 2.), and to show the relationship 
between baseline and post-intervention changes (Figure 3.) this is unlikely to have affected our 
results. 
 
4.4 - Implications for improving inspiratory muscle strength: 
By administering IMT to healthy older adults, it may be possible to prevent or delay the decline 
in inspiratory muscle strength in this population with inexpensive equipment and without 
requiring significant time. Evidence suggesting that respiratory muscle strength may be at the 
beginning of a causal chain leading to decreased pulmonary function and mortality [23] 
highlights the clinical importance of interventions, such as IMT, that can improve or maintain 





5.0 – Conclusion: 
Overall, this systematic review and meta-analysis provides evidence that IMT can be beneficial 
in an older population without the presence of a long-term condition; however, due to the high 
heterogeneity and large variation of methods it is difficult to draw concrete conclusions. There 
is a need for future studies to investigate the effect of IMT on functional capacity and quality 
of life in healthy older adults, and to determine whether IMT can reduce breathlessness and 
improve daily physical activity levels, which are associated with mortality in this population 
[46, 47].  
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